Filing Details
- Accession Number:
- 0001209191-17-035819
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 16:24:10
- Reporting Period:
- 2017-05-25
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 16:24:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187574 | Stuart Essig | 311 C Enterprise Drive Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-25 | 73,780 | $17.45 | 2,077,475 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-05-25 | 135,000 | $17.45 | 2,212,475 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-25 | 135,000 | $49.90 | 2,077,475 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-25 | 73,780 | $0.00 | 73,780 | $17.45 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-25 | 135,000 | $0.00 | 135,000 | $17.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 135,000 | 2017-12-18 | No | 4 | M | Direct | |
| 0 | 2017-12-18 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months.
Billionaire Hedge Funds
